ARA 290
Cibinetide, PHBSP, PH-BSP, Helix B surface peptide
An 11-amino acid peptide derived from erythropoietin, providing tissue protection, anti-inflammation, and neuroprotection without erythropoietic effects.
Unknown
PHASE2
NCT01933529
ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)
Claes-Göran Östenson
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT02638337
Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause
Shionogi
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT02039687
Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis
Araim Pharmaceuticals, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1, PHASE2
NCT02070783
Cognitive and Neural Effects of ARA290
Leiden University Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE2
NCT06626971
The Use of ARA290 for the Treatment of Diabetic Macular Oedema
Belfast Health and Social Care Trust
INTERVENTIONAL
Updated Dec 15, 2025